Prothena (PRTA) Stock Statistics & Valuation Metrics

Prothena has a market cap or net worth of $405.88M. The enterprise value is -$34.92M.

Prothena has 53,829,983 shares outstanding. The number of shares has decreased by -2.65% in one year.

Prothena’s return on equity (ROE) is -0.25 and return on invested capital (ROIC) is -29.25%.

The current PE Ratio of Prothena is ―. Prothena’s PEG ratio is ―.

In the last 12 months, Prothena had revenue of 135.16M and earned -122.31M in profits. Earnings per share was -2.27.

In the last 12 months, operating cash flow was -196.74M and capital expenditures -185.92K, giving a free cash flow of -196.69M billion.

Prothena pays an annual dividend of ―, resulting in a dividend yield of ―

Prothena upcoming earnings date is Oct 30, 2025, After Close (Confirmed).

Prothena as a current ratio of 10.01, with Debt / Equity ratio of 3.02%

In the past 12 months, Prothena has paid -6.62M in taxes.

Prothena EV to EBITDA ratio is -1.84, with an EV/FCF ratio of -1.89.

Prothena has $371.44M in cash and marketable securities with $9.78M in debt, giving a net cash position of -$361.65M billion.

Gross margin is 91.17%, with operating margin of -114.36%, and net profit margin of -90.49%.

The average price target for Prothena is $21.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy